Conservative Treatment with Octreotide as an Adjunct for Chylothorax after Lung Cancer Surgery: Two Cases.
- Author:
Suk Won SONG
1
;
Hyun Sung LEE
;
Moon Soo KIM
;
Jong Mog LEE
;
Jae Hyun KIM
;
Jae Ill ZO
Author Information
1. Center for Lung Cancer, Research Institute and Hospital, National Cancer Center, Korea. jaylzo@ncc.re.kr
- Publication Type:Case Report
- Keywords:
Chylothorax;
Drug therapy
- MeSH:
Chylothorax*;
Drug Therapy;
Humans;
Lung Neoplasms*;
Lung*;
Lymph Node Excision;
Octreotide*;
Thoracic Surgical Procedures
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2006;39(7):561-564
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Postoperative chylothorax is a rare but serious complication of thoracic surgical procedures. We report two cases of chylothorax after lobectomy and mediastinal lymph node dissection for lung cancer. The patients were successfully treated with subcutaneous octreotide injection as an adjunct to conservative treatment.
